Key result
Autonomic dysfunction is frequently present in patients with chronic liver disease, including precirrhotic stages, and is associated with symptoms and poor prognosis but is often overlooked.
Answers are grounded in this paper and cite their sources.
Autonomic dysfunction is common in both cirrhotic and precirrhotic liver disease, contributing to cardiovascular alterations and symptoms, yet remains frequently overlooked in clinical practice.
The autonomic nervous system (ANS) regulates the activities of cardiac muscle, smooth muscles, endocrine glands and exocrine glands, governing the unconscious body functions, including heart rate, blood pressure, body temperature, gastrointestinal secretion and motility and the metabolic/endocrine responses to stress such as the ‘fight or flight’ syndrome (1). As the ANS activity involves multiple organs, dysfunctions of the ANS usually encompass various and multiple disorders and may impair the quality of life. The ANS consists of three subsystems: the sympathetic nervous system, the parasympathetic nervous system and the enteric nervous system. Most target organs are innervated by neural fibres from both the parasympathetic (vagal) and the sympathetic systems, which act to stimulate organs in opposite ways (antagonistic). For example, vagal stimulation decreases heart rate, while sympathetic stimulation results in increased heart rate. Autonomic function can be easily investigated. Microneurography is one of the most accurate tests because it directly records the nerve sympathetic traffic, but it is an invasive and troublesome procedure (2). Other tests are time-consuming requiring long-term recording of vascular tone or heart rhythm. Nevertheless, there are many noninvasive and simple tests measuring heart rate, blood pressure and sweat function (see Table 1). These tests provide information about the nature and severity of autonomic disorders and have been used in the clinical setting to generate a large body of evidence on autonomic dysfunction (dysautonomia). Dysautonomia is usually characterized by the presence of hyper- or hypo-activity of one system or both, and can be primary (rare) or secondary. In the latter case, it can be the consequence of a neuropathy caused by drugs, toxins or antibodies (3). Neural dysfunction is often associated with chronic metabolic abnormalities, the most frequent being those occurring in patients with diabetes (4), where autonomic dysfunction causes postural hypotension, cardiac rhythm abnormalities, altered motility of the digestive tract, altered peripheral vascular tone and other less frequent but unpleasant symptoms. Autonomic dysfunctions have also been observed in patients with chronic liver disease (5). In most of these cases autonomic dysfunction has been attributed to an alcohol-mediated neuropathy, but other liver-related mechanisms are conceivable as chronic alcoholics with liver damage have higher frequency of neuropathy than those without it (6, 7). An interesting hypothesis in cirrhotic patients is that dysautonomia is one of the consequences of the peripheral vasodilation associated with portal hypertension. Peripheral vasodilation stimulates the release of angiotensin and catecholamines which interact with the control of the heart rate variability (HRV) (8). Prevalence of dysautonomia has been evaluated in unselected cohorts of patients with chronic liver disease. Barter and Tanner (6) studied a cohort of alcoholic patients, finding evidence of parasympathetic damage in 16% and of combined parasympathetic and sympathetic neuropathy in an additional 20% of them. Hendrikse et al. (9) found vagal neuropathy in 45% of patients with chronic liver disease, and Gentile et al. (10) reported autonomic neuropathy in 60% of their patients. In this last study autonomic dysfunction correlated with older age and more advanced liver disease as documented by low serum albumin levels and elevated Child–Pugh scores (9). In patients with cirrhosis dysautonomia has been suggested to predict poor prognosis (11). In a group of patients with advanced cirrhosis Trevisani et al. (12) found a significant correlation between autonomic dysfunction and the severity of hyperdynamic circulation, which is clearly associated with reduced survival. The mechanism linking dysautonomia and hyperdynamic circulation has been recently clarified by Liu et al. (13) who showed that hyperactivity of the vagal nerve, mediated by portal hypertension, stimulates the central mechanisms governing hyperdynamic circulation in rats with experimental prehepatic portal hypertension. Furthermore, dysautonomia in cirrhotic patients has been found to be associated with some clinically relevant cardiac alterations such as cardiac chronotropic incompetence (14), electromechanical uncoupling (15) and prolongation of the Q–T interval (16). It is conceivable that such cardiovascular alterations may explain some cardiac deaths due to malignant arrhythmia (17). Nevertheless, the issue of autonomic dysfunction in patients with chronic liver disease and particularly its clinical relevance, is mostly unknown and many doctors overlook the problem. Furthermore, symptoms of dysautonomia, such as hypotension and altered gut motility, are difficult to treat and can be induced by medications such as β-blockers and lactulose which are frequently prescribed to cirrhotics. Therefore, it is important to look for dysautonomia in any patients with any cause of hepatic disease. At the same time, prospective investigations should improve our insight into different issues of hepatic dysautonomia such as its pathophysiological basis, the role played in the generation of some cirrhotic symptoms and the influence on the prognosis of affected patients. Another issue which is still unclear is whether clinically relevant dysautonomia is present only in patients with cirrhosis or can it also occur in precirrhotic patients. In the present issue of Liver International there are two papers on dysautonomia in patients with chronic liver disease (18, 19). Osztovits et al. (18) investigated 45 noncirrhotic patients with chronic hepatitis due to hepatitis C virus and 40 healthy controls measuring spontaneous baroreflex sensitivity (BRS) and HRV, a measure of heart rate modulation by the ANS. The authors found that both BRS and HRV were lower in patients than in controls, so corroborating the view that dysautonomia also occurs before the liver becomes cirrhotic. The multivariate analysis showed an independent relationship between some indices of dysautonomia and the elevation of transaminases. By contrast, HCV viral load and blood levels of cryoglobulins were not related to autonomic changes. This, however, cannot exclude a pathogenetic role played by virus and cryoglobulins as their serum concentrations might widely fluctuate over time and are often unrelated to their tissue deposits (20, 21). In the second paper, Stevens et al. (19) studied a small cohort of patients with primary biliary cirrhosis (PBC) to evaluate if dysautonomia in these subjects is caused by a peripheral nervous system dysfunction in addition to the central dysfunction suggested by the evidence of structural lesions on brain magnetic resonance. Dysautonomia frequently occurs in patients with PBC, also in those in a precirrhotic stage (22), and it has been demonstrated to be closely related to symptoms of fatigue, cognitive dysfunction and postural dysregulation of blood pressure (22). Stevens et al. (19) used two sophisticated procedures, photoplethysmography and laser Doppler flowmetry, to record blood flow within the microcirculation in different body areas. Patients were studied both in resting state and after standing. The first assessed the static autonomic dysfunction, whereas the second assessed the dynamic autonomic dysfunction. The results are consistent with the hypothesis that autonomic dysfunction in PBC patients is, in part, of peripheral origin and mainly due to a defective activity of the sympathetic system. Moreover, the study of the veno-arteriolar reflex on standing showed a poorer autonomic vascular tone in PBC patients that may cause orthostatic hypotension. These findings open the way to new investigations, some of them addressed to understand what is the mechanism of the peripheral nervous dysfunction in PBC. Current hypotheses include an autoimmune mechanism as PBC is known to be frequently associated with autoimmune disorders of other organs. Mechanisms based on chronic cholestasis with bile salt retention and inflammatory cytokine release or with the peripheral accumulation of manganese or copper are also plausible (22). The clarification of these mechanisms will eventually allow improved treatment of common symptoms, such as fatigue and cognitive impairment, thus ameliorating the quality of life of such patients.
No takes yet. Share an insight, caveat, or question.
Salerno et al. (2009) conducted an editorial in Chronic liver disease and autonomic dysfunction. Autonomic dysfunction is frequently present in patients with chronic liver disease, including precirrhotic stages, and is associated with symptoms and poor prognosis but is often overlooked.
Synapse has enriched 10 related papers. Consider them for comparative context: